Simplex Trading
SPRB

Simplex Trading’s Spruce Biosciences SPRB Stock Holding History

Simplex Trading’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-32
Closed -$1K – 9863
2024
Q3 		$1K Sell
32
-1,313
-98% -$48.1K ﹤0.01% 8325
2024
Q2 		$52K Buy
+1,345
New +$72.1K ﹤0.01% 6052

Other funds holding SPRB

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Simplex Trading's SPRB Position: Q1 2025 in Review

Simplex Trading sold out of Spruce Biosciences (SPRB) in Q1 2025, closing a stake of 65 shares — an estimated $2K sold.

Simplex Trading first reported a position in SPRB in Q1 2024 and held it in 2 quarters. The position peaked at $22K in Q1 2024. 31 funds tracked by Wall St. Rank hold SPRB as of Q1 2025.

  • Simplex Trading reported no remaining Spruce Biosciences position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 65 Spruce Biosciences shares in Q1 2025, an estimated $2K.
  • Simplex Trading first reported a position in Spruce Biosciences in Q1 2024 and held it in 2 quarters.
  • Simplex Trading's Spruce Biosciences position peaked at $22K in Q1 2024.
  • 31 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.